Publikationen in Zusammenarbeit mit Forschern von Baylor College of Medicine (3)

2020

  1. FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease

    Journal of Clinical Investigation, Vol. 130, Núm. 9, pp. 4871-4887

2011

  1. Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer

    Clinical Proteomics, Vol. 8, Núm. 1

2010

  1. Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer

    Breast Cancer Research, Vol. 12, Núm. 3